Core Points - The company held its 33rd meeting of the 9th Board of Directors on August 28, 2025, where several key resolutions were passed [1][2][3] Group 1: Financial Reports - The Board approved the 2025 Half-Year Report and its summary, which was reviewed by the Audit Committee and received unanimous support from the directors [1] - A special report on the use of raised funds for the first half of 2025 was also approved [1] Group 2: Guarantees and Incentives - The Board approved a proposal to provide guarantees for a controlling subsidiary, stating that the financial risks are manageable and do not violate any regulations [2] - The first exercise conditions and the first release conditions of the 2023 stock option and restricted stock incentive plan were approved, with 19 eligible participants and a total of 620,350 shares [3] Group 3: Employee Stock Ownership Plan - The Board reviewed and approved the draft of the 2025 Employee Stock Ownership Plan and its management measures, aimed at enhancing employee engagement and company competitiveness [4][5] - The Board requested authorization from the shareholders' meeting to handle matters related to the employee stock ownership plan [5] Group 4: Corporate Governance - A proposal to cancel the Supervisory Board and amend the Articles of Association was approved, with the responsibilities of the Supervisory Board to be taken over by the Audit Committee [6] - The Board also approved the establishment of several internal management systems, including a Market Value Management System and a Major Information Internal Reporting System [7][8] Group 5: Upcoming Meetings - The Board proposed to hold the third extraordinary shareholders' meeting of 2025 on September 16, 2025, to review several key proposals [8]

Core Points - The document outlines the information disclosure deferral and exemption system for Suzhou Maiwei Technology Co., Ltd, ensuring compliance with relevant laws and regulations to protect investors' rights [1][2][3] - The company must adhere to the Shenzhen Stock Exchange's rules regarding the deferral and exemption of information disclosure, and it is subject to post-regulation by the exchange [3][4] - Information disclosure obligations must be fulfilled accurately and timely, without misuse of deferral or exemption to mislead investors or engage in illegal activities [4][5] Information Disclosure Deferral and Exemption Conditions - The company can defer or exempt disclosure if the information involves state secrets or could violate confidentiality regulations [5][6] - Commercial secrets can also be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [6][7] - If the reasons for deferral or exemption are resolved, or if the information becomes difficult to keep confidential, timely disclosure is required [7][8] Internal Management Procedures - The company must carefully determine the conditions for deferral or exemption and prevent unauthorized disclosure of such information [8][9] - Applications for deferral or exemption must be submitted to the board office, and the authenticity of the submitted materials is the responsibility of the relevant department or subsidiary [9][10] - A registration system is established to document the details of deferral or exemption, including the type of information and internal review procedures [10][11] Accountability and Compliance - The company has established a responsibility accountability mechanism for improper deferral or exemption of information disclosure, with potential consequences for responsible personnel [11][12] - All actions must comply with the latest laws, regulations, and the company's articles of association [12][13] - The board of directors is responsible for interpreting and revising the system, which takes effect upon approval [13][14]

Core Points - The document outlines the information disclosure deferral and exemption system for Guangdong Shenglu Communication Technology Co., Ltd, ensuring compliance with relevant laws and regulations while protecting investors' rights [1][8] - The company and other obligated parties must carefully determine deferral and exemption matters, following internal review procedures before implementation [3][5] Group 1: General Provisions - The system is established to regulate the deferral and exemption of information disclosure, ensuring compliance with the Company Law, Securities Law, and relevant stock exchange rules [1] - The company must disclose information accurately, completely, and timely, without abusing deferral or exemption to mislead investors [1][2] Group 2: Scope and Methods of Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or commercial secrets that could lead to unfair competition or harm to the company or others [2][6] - The company can use aliases, summaries, or omit key information in periodic reports if it involves state or commercial secrets [3][6] Group 3: Internal Review Procedures - Departments or subsidiaries must submit an application for deferral or exemption, ensuring the accuracy and completeness of the submitted materials [5][6] - The company must maintain records of deferral and exemption matters, including the type of documents and internal review procedures [6][7] Group 4: Accountability - The company has established a responsibility accountability mechanism for failing to report deferral or exemption matters in a timely manner, which may lead to negative impacts on the company and investors [7][8] Group 5: Miscellaneous - The system will take effect upon approval by the board of directors and must comply with relevant stock exchange rules and national laws [8][8]

Group 1 - The board of directors of Beijing Sunshine Nuohua Pharmaceutical Research Co., Ltd. held a meeting where all 9 directors attended, complying with relevant laws and regulations [1][2] - The board unanimously approved the proposal for the initial grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a grant date of June 11, 2025, and a grant price of 22.78 yuan per share for 1,277,428 shares to 127 eligible recipients [1][2] - The board also approved the addition of the "Information Disclosure Postponement and Exemption System" to regulate the company's information disclosure practices, ensuring compliance with various legal and regulatory requirements [2]